The Patent Finder
US

Biphenyl Compounds Useful as Muscarinic Receptor Antagonists

US 8,912,334 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Mar 10, 2025 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Sep 11, 2013 as application 14/023,794 · Granted Dec 16, 2014
Base term, 20 years from filing
Today
20 years from filing
Term ended Mar 10, 2025
2005 2026
Clock starts
Mar 10, 2005
Term ended
Mar 10, 2025
Granted
Dec 16, 2014
base term after the term ends fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,288,657, to Mar 10, 2025. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
16
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 10, 2005, when application 11/077,433, the earliest non-provisional in its chain, was filed (this one was filed Sep 11, 2013); a parent in its chain could not be resolved (the next row)Mar 10, 2025High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,288,657)resolves to Mar 10, 2025, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderMar 10, 2025Medium confidence

This family

US 7,288,657In force
Oct 2028
Oct 2028
US 8,017,783In force
Jan 2028
Jan 2028
US 8,912,334this patent
Mar 2025
Mar 2025
US 12,258,316Term ended
Oct 2026
Oct 2026
4 of 16 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 3, 2014
Reel 33118, frame 499
Theravance, Inc.Theravance Biopharma R&D IP, LLCAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited